Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

Go back to Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
(NYSE: NSRX) Delayed: 3.46 --0 (-0%)
Previous Close $3.46    52 Week High
Open $3.46    52 Week Low
Day High $3.46    P/E N/A 
Day Low $3.46    EPS
Volume 702